Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials • Medical Devices & Mechanical Engineering
10 pending office actions • 8 clients • 9 examiners • 8 art units • 0 of 10 (0%) have an AI response strategy ready
REMENICK PLLC has 9 pending office actions in Biotechnology & Pharmaceuticals and 845 career applications. Its resolved allowance rate is 81.32%, showing that allowance was reached in a substantial portion of resolved matters, while the record also includes matters that did not reach allowance.
The average is 4.6 office actions per allowance. This is a high level of recorded prosecution interaction for allowed matters, indicating that claim development may require repeated responses or amendments. The profile therefore points to meaningful biotechnology and pharmaceutical experience, paired with a prosecution process in which allowance can follow sustained examiner engagement.
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 2 (20%) |
| §103 only | 2 (20%) |
| §112 only | 1 (10%) |
| Double-patenting + other | 1 (10%) |
| Multi-statute (no §101) | 4 (40%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| FARDANESH, MARJAN | 2 | 72.6% | +19.0% |
| GANGLE, BRIAN J | 1 | 76.8% | +14.6% |
| THOMPSON, CAMIE S | 1 | 73.7% | +10.5% |
| NGUYEN, KHANH TUAN | 1 | 74.5% | +18.7% |
| JACOB, OOMMEN | 1 | 79.2% | +17.3% |
| BARRON, SEAN C | 1 | 52.7% | +30.4% |
| AMATO, ELIZABETH KATHRYN | 1 | 78.7% | +15.9% |
| GRASER, JENNIFER E | 1 | 76.8% | +23.2% |
| HOLLAND, PAUL J | 1 | 57.3% | +64.7% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 6 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18321195 | Moisture Protected Photoplethysmographic Laser Housing | FARDANESH, MARJAN | 52d overdue |
| 19074783 | FLEXIBLE IGNITION RESISTANT NON-ELECTRICALLY CONDUCTIVE BIREGIONAL FIBERS, ARTICLES MADE FROM NON- NON-ELECTRICALLY CONDUCTIVE BIREGIONAL FIBERS, AND METHODS OF MANUFACTURE | THOMPSON, CAMIE S | — |
| 18937464 | Bacterial Growth on Non-Animal Derived Media | BARRON, SEAN C | — |
| 18921204 | Advanced Respiratory Monitor and System | FARDANESH, MARJAN | — |
| 18686550 | COMPOSITIONS FOR MAKING BIODEGRADABLE PLASTIC | AMATO, ELIZABETH KATHRYN | — |
| 18162032 | Immunogenic Antigens | GRASER, JENNIFER E | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18321195 | Moisture Protected Photoplethysmographic Laser Housing | FARDANESH, MARJAN | 52d overdue |
| 17797851 | Production of Soluble Recombinant Protein | HOLLAND, PAUL J | 16d |
| 19334570 | Immunogenic Compositions of PEGylated Polysaccharide Compounds | GANGLE, BRIAN J | — |
| 19074783 | FLEXIBLE IGNITION RESISTANT NON-ELECTRICALLY CONDUCTIVE BIREGIONAL FIBERS, ARTICLES MADE FROM NON- NON-ELECTRICALLY CONDUCTIVE BIREGIONAL FIBERS, AND METHODS OF MANUFACTURE | THOMPSON, CAMIE S | — |
| 18727796 | NANOCELLULOSE-BASED AQUEOUS BINDER AND SLURRY FOR SECONDARY BATTERY ELECTRODE | NGUYEN, KHANH TUAN | — |
| 18970587 | Constant Current Drive for Lasers in Photoplethysmography | JACOB, OOMMEN | — |
| 18937464 | Bacterial Growth on Non-Animal Derived Media | BARRON, SEAN C | — |
| 18921204 | Advanced Respiratory Monitor and System | FARDANESH, MARJAN | — |
| Client (Assignee) | Pending OAs |
|---|---|
| Inventprise, Inc. | 2 |
| Zynex | 2 |
| Mariposa Monarca, LLC | 1 |
| Hansol Chemical Co., Ltd. | 1 |
| Respiratory Motion, Inc. | 1 |
| CTK RESEARCH AND DEVELOPMENT CANADA LTD. | 1 |
| Longhorn Vaccines | 1 |
| Fina BioSolutions, LLC | 1 |
| Art Unit | Apps |
|---|---|
| 1645 | 2 |
| 3791 | 2 |
| 1786 | 1 |
| 1761 | 1 |
| 3797 | 1 |
| 1653 | 1 |
| 1762 | 1 |
| 1656 | 1 |
| App # | Title | Client | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|---|
| 19334570 | Immunogenic Compositions of PEGylated Polysaccharide Compounds | Inventprise, Inc. | GANGLE, BRIAN J | 1645 | §102§112DP | Non-Final OA | — | Pending | Sep 19, 2025 |
| 19074783 | FLEXIBLE IGNITION RESISTANT NON-ELECTRICALLY CONDUCTIVE BIREGIONAL FIBERS, ARTICLES MADE FROM NON- NON-ELECTRICALLY CONDUCTIVE BIREGIONAL FIBERS, AND METHODS OF MANUFACTURE | Mariposa Monarca, LLC | THOMPSON, CAMIE S | 1786 | §101§112 | Non-Final OA | — | Pending | Mar 10, 2025 |
| 18727796 | NANOCELLULOSE-BASED AQUEOUS BINDER AND SLURRY FOR SECONDARY BATTERY ELECTRODE | Hansol Chemical Co., Ltd. | NGUYEN, KHANH TUAN | 1761 | §112 | Non-Final OA | — | Pending | Feb 14, 2025 |
| 18970587 | Constant Current Drive for Lasers in Photoplethysmography | Zynex Monitoring Solutions, Inc. | JACOB, OOMMEN | 3797 | §103 | Non-Final OA | — | Pending | Dec 05, 2024 |
| 18937464 | Bacterial Growth on Non-Animal Derived Media | Inventprise, Inc. | BARRON, SEAN C | 1653 | §103§112 | Non-Final OA | — | Pending | Nov 05, 2024 |
| 18921204 | Advanced Respiratory Monitor and System | Respiratory Motion, Inc. | FARDANESH, MARJAN | 3791 | §101§102Other | Non-Final OA | — | Pending | Oct 21, 2024 |
| 18686550 | COMPOSITIONS FOR MAKING BIODEGRADABLE PLASTIC | Ctk Research And Development Canada Ltd. | AMATO, ELIZABETH KATHRYN | 1762 | §102§103 | Non-Final OA | — | Pending | Feb 26, 2024 |
| 18321195 | Moisture Protected Photoplethysmographic Laser Housing | Zynex Monitoring Solutions, Inc. | FARDANESH, MARJAN | 3791 | §103§112 | Non-Final OA | 52d overdue | Pending | May 22, 2023 |
| 18162032 | Immunogenic Antigens | Longhorn Vaccines And Diagnostics, LLC | GRASER, JENNIFER E | 1645 | §102§112 | Final Rejection | — | Pending | Jan 31, 2023 |
| 17797851 | Production of Soluble Recombinant Protein | Fina Biosolutions, LLC | HOLLAND, PAUL J | 1656 | §103 | Final Rejection | 16d | Pending | Aug 05, 2022 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial81.3% of resolved applications prosecuted by Remenick Pllc were allowed, across 845 applications in USPTO records.
4.60 office actions per allowed application on average.
10 pending office actions as of October 2026, for 8 clients, before 9 examiners in 8 art units.
